HAE Dividend: Haemonetics Corp Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

HAE Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	03/29/2025	03/30/2024	04/01/2023	04/02/2022	04/03/2021
Revenue	1,327	1,360	1,309	1,168	993	870
Revenue Growth (YoY)	-3%	4%	12%	18%	14%	-12%
Cost of Revenue	551	597	600	545	467	462
Gross Profit	776	763	708	622	525	407
Selling, General & Admin	410	408	411	372	331	269
Research & Development	63	61	52	49	46	31
Operating Expenses	522	518	495	454	425	333
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	217	212	151	141	63	72
Income Tax Expense	48	44	34	26	20	-6
Net Income	168	167	117	115	43	79
Net Income Growth	37%	43%	2%	167%	-46%	4%
Shares Outstanding (Diluted)	47.66	50.73	51.39	51.4	51.4	51.3
Shares Change (YoY)	-7%	-1%	0%	0%	0%	-1%
EPS (Diluted)	3.52	3.3	2.28	2.24	0.84	1.55
EPS Growth	46%	45%	2%	167%	-46%	5%
Free Cash Flow	212	121	115	162	75	71
Free Cash Flow Per Share	4.44	2.38	2.23	3.15	1.45	1.38
Gross Margin	58.47%	56.1%	54.08%	53.25%	52.87%	46.78%
Operating Margin	19.06%	18.01%	16.27%	14.38%	10.07%	8.39%
Profit Margin	12.66%	12.27%	8.93%	9.84%	4.33%	9.08%
Free Cash Flow Margin	15.97%	8.89%	8.78%	13.86%	7.55%	8.16%
EBITDA	367	360	310	261	197	157
EBITDA Margin	27.65%	26.47%	23.68%	22.34%	19.83%	18.04%
D&A For EBITDA	114	115	97	93	97	84
EBIT	253	245	213	168	100	73
EBIT Margin	19.06%	18.01%	16.27%	14.38%	10.07%	8.39%
Effective Tax Rate	22.11%	20.75%	22.51%	18.43%	31.74%	-8.33%